Recent advances in the pharmacological diversification of quinazoline/quinazolinone hybrids

PS Auti, G George, AT Paul - RSC advances, 2020 - pubs.rsc.org
Due to the pharmacological activities of quinazoline and quinazolinone scaffolds, it has
aroused great interest in medicinal chemists for the development of new drugs or drug …

Potential impact of the multi-target drug approach in the treatment of some complex diseases

XH Makhoba, C Viegas Jr, RA Mosa… - Drug design …, 2020 - Taylor & Francis
It is essential to acknowledge the efforts made thus far to manage or eliminate various
disease burden faced by humankind. However, the rising global trends of the so-called …

A perspective on multi-target drug discovery and design for complex diseases

RR Ramsay, MR Popovic-Nikolic, K Nikolic… - Clinical and translational …, 2018 - Springer
Diseases of infection, of neurodegeneration (such as Alzheimer's and Parkinson's
diseases), and of malignancy (cancers) have complex and varied causative factors. Modern …

Molecular hybridization as a tool for designing multitarget drug candidates for complex diseases

V Ivasiv, C Albertini, AE Gonçalves… - Current Topics in …, 2019 - ingentaconnect.com
Molecular hybridization is a well-exploited medicinal chemistry strategy that aims to combine
two molecules (or parts of them) in a new, single chemical entity. Recently, it has been …

Polypharmacology: The science of multi-targeting molecules

A Kabir, A Muth - Pharmacological Research, 2022 - Elsevier
Polypharmacology is a concept where a molecule can interact with two or more targets
simultaneously. It offers many advantages as compared to the conventional single-targeting …

Network-based modeling of herb combinations in traditional Chinese medicine

Y Wang, H Yang, L Chen, M Jafari… - Briefings in …, 2021 - academic.oup.com
Traditional Chinese medicine (TCM) has been practiced for thousands of years for treating
human diseases. In comparison to modern medicine, one of the advantages of TCM is the …

An omics perspective on drug target discovery platforms

J Paananen, V Fortino - Briefings in bioinformatics, 2020 - academic.oup.com
The drug discovery process starts with identification of a disease-modifying target. This
critical step traditionally begins with manual investigation of scientific literature and …

Thermodynamics and kinetics of drug-target binding by molecular simulation

S Decherchi, A Cavalli - Chemical Reviews, 2020 - ACS Publications
Computational studies play an increasingly important role in chemistry and biophysics,
mainly thanks to improvements in hardware and algorithms. In drug discovery and …

Current and future therapeutic strategies for Alzheimer's disease: An overview of drug development bottlenecks

Y Peng, H Jin, Y Xue, Q Chen, S Yao, M Du… - Frontiers in aging …, 2023 - frontiersin.org
Alzheimer's disease (AD) is the most common chronic neurodegenerative disease
worldwide. It causes cognitive dysfunction, such as aphasia and agnosia, and mental …

Anticancer thiosemicarbazones: chemical properties, interaction with iron metabolism, and resistance development

FS PapeVeronika, A EnyedyÉva… - Antioxidants & redox …, 2019 - liebertpub.com
Significance: During the past decades, thiosemicarbazones were clinically developed for a
variety of diseases, including tuberculosis, viral infections, malaria, and cancer. With regard …